Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
Process Chemistry in the Pharmaceutical Industry
September 28 – 30, 2008 | The Royal Sonesta Boston | Boston, MA
| Type | Conference |
|---|---|
| Language | English |
| Date |
September 28, 2008
to September 30, 2008 |
| Venue |
The Royal Sonesta Boston | Boston, MA , |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
ACS Perspectives , US 1- (800) 227-5558 acsprospectives@acs.org |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
New conference chairs Pat Confalone of DuPont and Joseph Fortunak of Howard University have developed the 2008 program for the “Process Chemistry in the Pharmaceutical Industry” conference with an emphasis on process R&D and a look into how another industry navigates the issues of commercial ramp up and manufacturing. A number of case studies from the pharmaceutical industry will be given to highlight the challenges and rewards of discovering and developing commercial manufacturing processes for novel therapeutics. The engineering aspects of process R&D, including kinetics, process parameters, process analytical technology, and green chemistry, will also be explored. A half-day will be devoted to presentations from the crop protection sector, where cost of goods is a critical success factor, and practitioners must develop commercial processes within severe cost constraints in the face of complex active ingredient targets. This requires highly convergent syntheses with starting material pricing less than $ 10 / kg, often eliminating several excellent alternative routes for the manufacturing process. Many of the insights from the Agrichemicals industry should prove beneficial to pharmaceutical Process R&D organizations. Though the focus of the conference is on process chemistry currently in practice in industry, as always, noted academics will present their ideas and work on important novel methodologies that will impact process R&D capabilities in the near future.